SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001079973-23-001412
Filing Date
2023-10-11
Accepted
2023-10-11 16:40:09
Documents
14
Period of Report
2023-10-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K opgen_8k.htm   iXBRL 8-K 31595
2 CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES D PR ex3x1.htm EX-3.1 89397
3 PREFERRED STOCK PURCHASE AGREEMENT ex10x1.htm EX-10.1 108482
  Complete submission text file 0001079973-23-001412.txt   453444

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE opgn-20231011.xsd EX-101.SCH 3006
5 XBRL LABEL FILE opgn-20231011_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE opgn-20231011_pre.xml EX-101.PRE 22353
8 EXTRACTED XBRL INSTANCE DOCUMENT opgen_8k_htm.xml XML 3376
Mailing Address 9717 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850
Business Address 9717 KEY WEST AVENUE SUITE 100 ROCKVILLE MD 20850 301-869-9683
OPGEN INC (Filer) CIK: 0001293818 (see all company filings)

IRS No.: 061614015 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37367 | Film No.: 231321064
SIC: 8071 Services-Medical Laboratories